Jose María Mateo Aguado-rekin lankidetzan egindako argitalpenak (70)

2014

  1. Kinetics of peripheral blood lymphocyte subpopulations predicts the occurrence of opportunistic infection after kidney transplantation

    Transplant International, Vol. 27, Núm. 7, pp. 674-685

2013

  1. A non-compulsory stewardship programme for the management of antifungals in a university-affiliated hospital

    Clinical Microbiology and Infection, Vol. 19, Núm. 1, pp. 56-61

  2. Epidemiology, risk factors and impact on long-term pancreatic function of infection following pancreas-kidney transplantation

    Clinical Microbiology and Infection, Vol. 19, Núm. 12, pp. 1132-1139

  3. Epstein-barr virus DNAemia is an early surrogate marker of the net state of immunosuppresion in solid organ transplant recipients

    Transplantation, Vol. 95, Núm. 5, pp. 688-693

  4. Hypocomplementemia in kidney transplant recipients: Impact on the risk of infectious complications

    American Journal of Transplantation, Vol. 13, Núm. 3, pp. 685-694

  5. Infection risk in kidney transplantation from uncontrolled donation after circulatory death donors

    Transplantation Proceedings

  6. Influence of antiviral therapy in the long-term outcome of recurrent hepatitis C virus infection following liver transplantation

    Transplant Infectious Disease, Vol. 15, Núm. 4, pp. 405-415

  7. Limited impact of cytomegalovirus infection in the long-term outcome of renal and liver transplant

    Journal of Clinical Virology, Vol. 56, Núm. 4, pp. 316-322

  8. Serum iron parameters in the early post-transplant period and infection risk in kidney transplant recipients

    Transplant Infectious Disease, Vol. 15, Núm. 6, pp. 600-611

2012

  1. Monitoring of immunoglobulin levels identifies kidney transplant recipients at high risk of infection

    American Journal of Transplantation, Vol. 12, Núm. 10, pp. 2763-2773

2011

  1. GESITRA-SEIMC/REIPI recommendations for the management of cytomegalovirus infection in solid-organ transplant patients Recomendaciones GESITRA-SEIMC/REIPI para el manejo de la infección por citomegalovirus en pacientes trasplantados de órgano sólido

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 29, Núm. 10, pp. 735-758

  2. Guidelines for the treatment of invasive fungal disease by Aspergillus spp. and other fungi issued by the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC). 2011 Update

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 29, Núm. 6, pp. 435-454

  3. Impact of hepatitis C virus infection on the risk of infectious complications after kidney transplantation: Data from the RESITRA/REIPI cohort

    Transplantation, Vol. 92, Núm. 5, pp. 543-549

  4. Selective intestinal decontamination with fluoroquinolones for the prevention of early bacterial infections after liver transplantation

    Liver Transplantation, Vol. 17, Núm. 8, pp. 896-904

  5. Universal prophylaxis with fluconazole for the prevention of early invasive fungal infection in low-risk liver transplant recipients

    Transplantation, Vol. 92, Núm. 3, pp. 346-350

2009

  1. A new strategy of delayed long-term prophylaxis could prevent cytomegalovirus disease in (D+/R-) solid organ transplant recipients

    Clinical Transplantation, Vol. 23, Núm. 5, pp. 666-671

2008

  1. Impact of current transplantation management on the development of cytomegalovirus disease after renal transplantation

    Clinical Infectious Diseases, Vol. 47, Núm. 7, pp. 875-882

2007

  1. Clinical implications of respiratory virus infections in solid organ transplant recipients: A prospective study

    Transplantation, Vol. 84, Núm. 7, pp. 851-856

  2. Incidence, clinical characteristics and risk factors of late infection in solid organ transplant recipients: Data from the RESITRA Study Group

    American Journal of Transplantation, Vol. 7, Núm. 4, pp. 964-971

  3. Infecciones en los pacientes trasplantados de hígado

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 25, Núm. 6, pp. 401-410